Qiu’s Cervical Prescription inhibit the invasion and growth of cervical cancer through LncRNA ATB/miR-126 pathway DOI
Yingping Zhu, Yang Lv,

Haili Yao

et al.

Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 266, P. 155784 - 155784

Published: Dec. 20, 2024

Language: Английский

Signaling pathways governing glioma cancer stem cells behavior DOI
Ava Nasrolahi, Shirin Azizidoost, Klaudia Radoszkiewicz

et al.

Cellular Signalling, Journal Year: 2022, Volume and Issue: 101, P. 110493 - 110493

Published: Oct. 11, 2022

Language: Английский

Citations

30
Functional roles of lncRNA-TUG1 in hepatocellular carcinoma DOI

Maryam Farzaneh,

Majid Ghasemian, Farhoodeh Ghaedrahmati

et al.

Life Sciences, Journal Year: 2022, Volume and Issue: 308, P. 120974 - 120974

Published: Sept. 17, 2022

Language: Английский

Citations

29
Long Non-Coding RNAs in Colorectal Cancer: Navigating the Intersections of Immunity, Intercellular Communication, and Therapeutic Potential DOI Creative Commons
Nikolay K. Shakhpazyan, Л.М. Михалева, A.L. Bedzhanyan

et al.

Biomedicines, Journal Year: 2023, Volume and Issue: 11(9), P. 2411 - 2411

Published: Aug. 28, 2023

This comprehensive review elucidates the intricate roles of long non-coding RNAs (lncRNAs) within colorectal cancer (CRC) microenvironment, intersecting domains immunity, intercellular communication, and therapeutic potential. lncRNAs, which are significantly involved in pathogenesis CRC, immune evasion, treatment response to have crucial implications inflammation serve as promising candidates for novel strategies biomarkers. scrutinizes interaction lncRNAs with Consensus Molecular Subtypes (CMSs) their complex interplay tumor stroma affecting immunity inflammation, conveyance via extracellular vesicles, particularly exosomes. Furthermore, we delve into relationship between other RNAs, including microRNAs circular mediating cell-to-cell communication CRC microenvironment. Lastly, propose potential manipulate enhance anti-tumor thereby underlining significance devising innovative interventions CRC.

Language: Английский

Citations

19
LncRNA MALAT1-related signaling pathways in osteosarcoma DOI

Maryam Farzaneh,

Sajad Najafi, Omid Anbiyaee

et al.

Clinical & Translational Oncology, Journal Year: 2022, Volume and Issue: 25(1), P. 21 - 32

Published: July 6, 2022

Language: Английский

Citations

24
Crosstalk between long non-coding RNAs and p53 signaling pathway in colorectal cancer: A review study DOI

Mohammad Mahdi Khanifar,

Zahra Zafari, Mohsen Sheykhhasan

et al.

Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 249, P. 154756 - 154756

Published: Aug. 10, 2023

Language: Английский

Citations

15
Potential roles of lncRNA-XIST/miRNAs/mRNAs in human cancer cells DOI

Maryam Farzaneh,

Ava Nasrolahi, Farhoodeh Ghaedrahmati

et al.

Clinical & Translational Oncology, Journal Year: 2023, Volume and Issue: 25(7), P. 2015 - 2042

Published: Feb. 28, 2023

Language: Английский

Citations

11
Regulation of immune-mediated chemoresistance in cancer by lncRNAs: an in-depth review of signaling pathways DOI
Saade Abdalkareem Jasim, Farag M. A. Altalbawy, Subasini Uthirapathy

et al.

Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2025, Volume and Issue: unknown

Published: April 9, 2025

Language: Английский

Citations

0
The pathogenic roles of lncRNA-Taurine upregulated 1 (TUG1) in colorectal cancer DOI Creative Commons
Shirin Azizidoost, Ava Nasrolahi, Farhoodeh Ghaedrahmati

et al.

Cancer Cell International, Journal Year: 2022, Volume and Issue: 22(1)

Published: Nov. 4, 2022

Abstract Colorectal cancer (CRC) is a gastrointestinal tumor that develops from the colon, rectum, or appendix. The prognosis of CRC patients especially those with metastatic lesions remains unsatisfactory. Although various conventional methods have been used for treatment CRC, early detection and identification molecular mechanisms associated necessary. scientific literature reports altered expression long non-coding RNAs (lncRNAs) contributed to pathogenesis cells. LncRNA TUG1 was reported target miRNAs signaling pathways mediate cell proliferation, migration, metastasis. Therefore, might be potent predictive/prognostic biomarker diagnosis CRC.

Language: Английский

Citations

13
Astragaloside IV inhibits epithelial-mesenchymal transition and pulmonary fibrosis via lncRNA-ATB/miR-200c/ZEB1 signaling pathway DOI

Yanyun Guan,

Juan Zhang, Xinrui Cai

et al.

Gene, Journal Year: 2023, Volume and Issue: 897, P. 148040 - 148040

Published: Dec. 6, 2023

Language: Английский

Citations

7
LncRNA THUMPD3-AS1 promotes invasion and EMT in gastric cancer by regulating the miR-1297/BCAT1 pathway DOI Creative Commons
Zaibo Zhang, Yong Li, Liqiao Fan

et al.

iScience, Journal Year: 2023, Volume and Issue: 26(9), P. 107673 - 107673

Published: Aug. 18, 2023

Long noncoding RNA (lncRNA) plays crucial roles in the development of gastric cancer (GC); however, studies their mechanisms action are needed to determine clinical value. The aim this study is explore effects and THUMPD3-AS1 GC. Elevated levels were observed GC demonstrated a significant positive correlation with poor prognosis. Functionally, promoted cell proliferation, migration, invasion, epithelial-mesenchymal transition (EMT) induced tumor growth vivo. exerts its regulatory function on BCAT1 through competitive binding miR-1297. Further investigations confirmed that both miR-1297 interact BCAT1. These findings suggest promotes invasion EMT by regulating miR-1297/BCAT1 pathway, indicating may serve as biomarker therapeutic target for

Language: Английский

Citations

6